Tianlu Huang

Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in Cholangiocarcinoma

K. Ahn, H. Friess, L. Roberts, 2020, Journal of Cancer.

Safety and efficacy of endoscopic ultrasound‐guided gastroenterostomy for gastric outlet obstruction in different sites: A single‐center retrospective study

X. Zou, Lei Wang, Ying Lv, 2022, Journal of digestive diseases.

CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263

Yu Cao, X. Zou, Lei Wang, 2019, Cell Death & Disease.

Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

H. Friess, L. Roberts, X. Zou, 2019, American journal of cancer research.

BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells.

Zhenqing Feng, Yang Li, X. Zou, 2019, American journal of translational research.